Our latest news
The latest in Breast AI with ScreenPoint Medical
Explore our upcoming events and the latest media coverage to see how Transpara® is redefining breast imaging for those leading the way in breast health.
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
Originally posted on PR Newswire.
September 23, 2025
ScreenPoint Medical expands in Spain with SACYL - EUSOBI 2025
.png)
ScreenPoint Medical expands in Spain with SACYL - EUSOBI 2025
Nijmegen, The Netherlands and Castilla y León, Spain September 24, 2025 – Today, S…
September 23, 2025
New study assesses cost-effectiveness of Transpara as part of national screening protocol
.png)
New study assesses cost-effectiveness of Transpara as part of national screening protocol
As mammography screening programs around the world seek to adopt artificial intell…
July 29, 2025
.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp)